27 Apr 2015
NeurOp Announces Strategic Collaboration with Johnson & Johnson Innovation to St ...
2 Oct 2014
NeurOp Receives Milestone Payment as Bristol-Myers Squibb Nominates NMDA Recepto ...
Based in Atlanta, NeurOp was founded in 2002 by Raymond Dingledine, Ph.D., and Stephen Traynelis, Ph.D., both of the department of
pharmacology at Emory University School of Medicine, and James McNamara, M.D., chairman of the neurobiology department at Duke
University Medical Center. Through their collaboration, these researchers were able to translate years of rigorous investigation
of a critical signaling pathway in the central nervous system into promising drug compounds.
NeurOp scientists are today refining these promising leads to create more effective and safe
medicines for the treatment of major depression, neuropathic pain, ischemia and other indications. Our expertise in the
neuropharmacology of drugs that interact with the NMDA receptor is evident in the strength of
our Management Team and Scientific Founders & Board of Directors.